PROK vs GRML โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PROK Captures Institutional Edge (2โ1 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ProKidney Corp. Class A Ordinary Shares (PROK) driven by superior Growth & Margin, Options & Structure while GRML counters with relative strength in Momentum & Technical. Fundamentally, PROK trades at N/M Forward P/E with -24830.3% operating margin (-19.8% YoY revenue) versus GRML at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, PROK sits in BREAKDOWN (42nd %ile IV; Dealer Gamma Walls on Pro) against GRML sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PROK | GRML | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $415.2M | N/A | Larger Scale | PROK |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -19.8% | N/A | Higher Growth | PROK |
| Operating Margin (TTM) Profitability | -24830.3% | N/A | Higher Margin | PROK |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | PROK |
| Return on Equity (ROE) Capital Efficiency | -73.4% | N/A | Higher ROE | PROK |
| 52-Week Range Position Momentum | 9% ($1โ$3) | 19% ($0โ$18) | Stronger Trend | GRML |
| Beta / 30D Volatility Risk Regime | 1.70ฮฒ ยท 92% Vol | -5.32ฮฒ ยท 95% Vol | Lower Realized Risk | PROK |
| Unified Institutional Score Composite Signal | 54.0 / 100 (HOLD) | 56.8 / 100 (HOLD) | Higher Composite | GRML |